Opendata, web and dolomites

iPLACENTA SIGNED

Innovation in modelling Placenta for Maternal and Fetal Health

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iPLACENTA project word cloud

Explore the words cloud of the iPLACENTA project. It provides you a very rough idea of what is the project "iPLACENTA" about.

world    etn    companies    validate    businesses    sectorial    global    nih    maternal    industrial    models    tools    placenta    clinicians    vivo    business    fujiffilm    clinic    animal    modalities    springboard    brings    sam    wp1    coordinates    least    universities    mathematical    prognosis    combination    academic    wp3    beneficiaries    iplacenta    clinical    arguably    diagnosis    network    cardiovascular    fuj    industry    pregnancies    inter    countries    moor    fetal    organ    complicated    investigation    brands    wp2    visualise    health    academics    training    model    located    visualsonics    specialist    schools    developer    cross    openinnovation    ultrasound    participating    mimetas    intersectoral    laser    stage    mim    ten    chip    leaders    link    openscience    expertise    visualisation    career    esrs    disciplinary    act    human    law    samsung    delivered    fifteen    silico    doctoral    international    innovation    vitro    whilst    eleven   

Project "iPLACENTA" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF DUNDEE 

Organization address
address: Nethergate
city: DUNDEE
postcode: DD1 4HN
website: www.dundee.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 3˙929˙698 €
 EC max contribution 3˙929˙698 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF DUNDEE UK (DUNDEE) coordinator 546˙575.00
2    ST GEORGE'S HOSPITAL MEDICAL SCHOOL UK (LONDON) participant 546˙575.00
3    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 525˙751.00
4    MIMETAS BV NL (Leiden) participant 510˙748.00
5    ASTON UNIVERSITY UK (BIRMINGHAM) participant 273˙287.00
6    UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK IE (Cork) participant 265˙674.00
7    UNIVERSITA DEGLI STUDI DI TORINO IT (TORINO) participant 258˙061.00
8    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 255˙374.00
9    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 250˙560.00
10    UNIVERSITAET ROSTOCK DE (ROSTOCK) participant 249˙216.00
11    FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA ES (VALENCIA) participant 247˙872.00
12    Action on Pre-Eclampsia UK (Evesham) partner 0.00
13    EUROPEAN FOUNDATION FOR THE CARE OF NEWBORN INFANTS DE (MUNCHEN) partner 0.00
14    Facilitate Open Science Training for European Research PT (Braga) partner 0.00
15    FUJIFILM VisualSonics NL (Amsterdam) partner 0.00
16    ISTANBUL UNIVERSITESI TR (ISTANBUL) partner 0.00
17    Samsung Healthcare KR (Seúl) partner 0.00
18    University of Helsinki FI (Helsinki) partner 0.00

Map

 Project objective

“The placenta is the least understood human organ but arguably one of the most important”-NIH Human Placenta Project . Innovation in Modelling Placenta for Maternal and Fetal Health (iPLACENTA) is a European Training Network (ETN), and will act as a springboard for promoting international, intersectoral and multi/inter-disciplinary training, career development and collaboration of fifteen early-stage researchers (ESRs) in Maternal and Fetal Health. iPLACENTA will improve our ability to study, model and visualise the placenta. iPLACENTA focuses on doctoral-level training and will be delivered by eleven participating universities located in ten different European countries. It coordinates research and training collaboration among world-leading academic institutions in Europe, providing a new combination of in-depth international expertise. iPLACENTA’s unique network aims are to improve our ability to study the placenta through in vitro and mathematical modelling (WP1&2). Whilst enhancing visualisation and assessment of the placenta in animal models and the clinic, thus enhancing investigation and prognosis of complicated pregnancies. To link the research to industrial exploitation, the network brings together four different businesses; two established companies as beneficiaries Mimetas (MIM) (organ-on-a-chip developer) and Moor, a clinical-technology specialist, together with two partners that are industrial global brands Samsung (SAM) and FujifFilm VisualSonics (FUJ). Together they will work with academics and clinicians to develop new placenta-on-a-chip technology (WP1), in silico placenta modelling (WP2), new modalities of laser technology to visualise the placenta in vivo (WP3), improve maternal-cardiovascular assessment and validate novel ultrasound tools for diagnosis of complicated pregnancies (WP3). Cross-sectorial training delivered by Business and Law Schools, Industry, Clinical specialist and European leaders in OpenScience-OpenInnovation.

 Publications

year authors and title journal last update
List of publications.
2020 Karen Melchiorre, Basky Thilaganathan, Veronica Giorgione, Anna Ridder, Alessia Memmo, Asma Khalil
Hypertensive Disorders of Pregnancy and Future Cardiovascular Health
published pages: , ISSN: 2297-055X, DOI: 10.3389/fcvm.2020.00059
Frontiers in Cardiovascular Medicine 7 2020-04-24
2020 Soragni C, Rabussier G, Lanz HL, de Windt LJ, Trietsch SJ, Ng CP
Barrier integrity of HUVEC cultured in 3-lane Organoplate® with low level of oxygen
published pages: , ISSN: , DOI:
International Cell Culture Under Flow Meeting 2020, Abstract Book 2020 2020-03-05
2019 ​Loscalzo G, Moralles-Roselló J, García Gimenez JL, Martinez Priego L, González-Rodríguez D, Mena Mollá S, Maquieira Catalá A, Buongiorno S, Cañada Martínez AJ, Perales Marín A
​MicroRNA-148B-3P and MicroRNA-25-3P are overexpressed in fetuses with late-onset fetal growth restriction
published pages: Abstract 28, ISSN: , DOI:
8th International Conference on Fetal Growth 2019 2019-11-28
2019 Lermant, Murdoch
Cysteine Glutathionylation Acts as a Redox Switch in Endothelial Cells
published pages: 315, ISSN: 2076-3921, DOI: 10.3390/antiox8080315
Antioxidants 8/8 2019-08-29
2019 Anna Ridder, Veronica Giorgione, Asma Khalil, Basky Thilaganathan
Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function
published pages: 3263, ISSN: 1422-0067, DOI: 10.3390/ijms20133263
International Journal of Molecular Sciences 20/13 2019-09-02
2019 Clara Apicella, Camino S. M. Ruano, Céline Méhats, Francisco Miralles, Daniel Vaiman
The Role of Epigenetics in Placental Development and the Etiology of Preeclampsia
published pages: 2837, ISSN: 1422-0067, DOI: 10.3390/ijms20112837
International Journal of Molecular Sciences 20/11 2019-09-02
2019 Samprikta Manna, Cathal McCarthy, Fergus P. McCarthy
Placental Ageing in Adverse Pregnancy Outcomes: Telomere Shortening, Cell Senescence, and Mitochondrial Dysfunction
published pages: 1-11, ISSN: 1942-0900, DOI: 10.1155/2019/3095383
Oxidative Medicine and Cellular Longevity 2019 2019-07-08
2019 Basky Thilaganathan, Erkan Kalafat
Cardiovascular System in Preeclampsia and Beyond
published pages: 522-531, ISSN: 0194-911X, DOI: 10.1161/hypertensionaha.118.11191
Hypertension 73/3 2019-08-05
2018 Dongqing Guo, Colin E. Murdoch, Tianhua Liu, Jia Qu, Shihong Jiao, Yong Wang, Wei Wang, Xing Chen
Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review
published pages: , ISSN: 1663-9812, DOI: 10.3389/fphar.2018.00428
Frontiers in Pharmacology 9 2019-07-08

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IPLACENTA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IPLACENTA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

SuperCol (2020)

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Read More  

NL4XAI (2019)

Interactive Natural Language Technology for Explainable Artificial Intelligence

Read More